Affiliation:
1. Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology University of Bergen Bergen Norway
2. Department of Medicine Haukeland University Hospital Bergen Norway
3. Department of Pathology Haukeland University Hospital Bergen Norway
Abstract
AbstractAngiogenesis is recognized as a hallmark of cancer, and vascular endothelial growth factor (VEGF) is a key regulator of the angiogenic process and is related to cancer progression. Anti‐VEGF therapy has been tried but with limited success and without useful stratification for angiogenesis markers. Further, the landscape of VEGF single nucleotide polymorphisms (SNPs) in breast cancer and their clinical relevance is not well studied, and their relation to tissue‐based angiogenesis markers has not been explored. Here, we studied a selection of VEGFA SNPs in nontumor lymph nodes from a population‐based breast cancer cohort (n = 544), and their relation to clinicopathologic variables, vascular tissue metrics, and breast cancer‐specific survival. Two of the SNP candidates (rs833068GA genotype and rs25648CC genotype) showed associations with angiogenesis tissue markers, and the VEGFA rs833068GA genotype was associated with breast cancer‐specific survival among ER‐negative cases. We also found trends of association between the rs699947CA genotype and large tumor diameter and ER‐negative tumors, and between the rs3025039CC genotype and large tumor diameter. Our findings indicate some associations between certain VEGF SNPs, in particular the rs833068GA genotype, and both vascular metrics and patient survival. These findings and their potential implications need to be validated by independent studies.